Videos

Analyst Moves: BMY, BBBY

Market News Video
|
June 23, 2011 AT 1:47 PM
This morning, Morgan Stanley upgraded shares of Bristol-Myers Squibb (BMY) from equal weight to overweight as the company's product pipeline remains robust. With the upgrade, Morgan Stanley set a price target of $34 per share.